Glatiramer Subcutaneous and Oxcarbazepine Extended-Release Tablets
Determining the interaction of Glatiramer Subcutaneous and Oxcarbazepine Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glatiramer
Brand name: Copaxone, Glatopa
Synonyms: Glatiramer (injection), Glatiramer Acetate
Generic Name: oxcarbazepine
Brand name: Oxtellar XR, Trileptal
Synonyms: Oxcarbazepine, OXcarbazepine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glatiramer Subcutaneous-Oxcarbazepine Oral Suspension
- Glatiramer Subcutaneous-Oxcarbazepine Suspension
- Glatiramer Subcutaneous-Oxcarbazepine Tablets
- Glatiramer Subcutaneous-Oxecta
- Glatiramer Subcutaneous-Oxilan
- Glatiramer Subcutaneous-Oxipor VHC
- Oxcarbazepine Extended-Release Tablets-Glatopa
- Oxcarbazepine Extended-Release Tablets-Glatopa injection
- Oxcarbazepine Extended-Release Tablets-Glecaprevir and pibrentasvir
- Oxcarbazepine Extended-Release Tablets-Gleevec
- Oxcarbazepine Extended-Release Tablets-Glenmax PEB DM
- Oxcarbazepine Extended-Release Tablets-Glenmax PEB DM FORTE